Zobrazeno 1 - 10
of 33
pro vyhledávání: '"M. Farnebo"'
Autor:
M Farnebo
Publikováno v:
Atlas of Genetics and Cytogenetics in Oncology and Haematology.
Review on WRAP53 (WD repeat containing, antisense to TP53), with data on DNA, on the protein encoded, and where the gene is implicated.
13 Proffered Paper: The Cajal Body Protein WRAP53β - a Novel Player in the Early DNA Damage Response
Publikováno v:
European Journal of Cancer. 48:S3-S4
Autor:
A.L. Børresen-Dale, H. Russnes, L. Silwal-Pandit, A. Langerad, M. Farnebo, Bjørn Naume, Elin Borgen
Publikováno v:
European Journal of Cancer. 48:S200
Autor:
Egelberg M; Division of Surgery, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Sweden.; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Sweden.; Department of Radiology, Kristianstad Hospital, Sweden., De Marchi T; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Sweden., Pekar G; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Sweden., Tran L; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Sweden., Bendahl PO; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Sweden., Tullberg AS; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrenska University Hospital, University of Gothenburg, Sweden., Holmberg E; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrenska University Hospital, University of Gothenburg, Sweden., Karlsson P; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrenska University Hospital, University of Gothenburg, Sweden., Farnebo M; Department of Bioscience and Nutrition & Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden., Killander F; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Sweden.; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Skåne University Hospital, Lund, Sweden., Nimeús E; Division of Surgery, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Sweden.; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Sweden.; Division of Surgery, Department of Clinical Sciences Lund, Faculty of Medicine, Skåne University Hospital, Lund, Sweden.
Publikováno v:
Molecular oncology [Mol Oncol] 2023 Oct; Vol. 17 (10), pp. 2029-2040. Date of Electronic Publication: 2023 Apr 19.
Autor:
Pederiva C; Department of Cell and Molecular Biology, Karolinska Institutet, Solna 17165, Sweden., Trevisan DM; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge 14152, Sweden., Peirasmaki D; Department of Cell and Molecular Biology, Karolinska Institutet, Solna 17165, Sweden., Chen S; Department of Oncology and Pathology, Karolinska Institutet, Solna 17165, Sweden.; Science for Life Laboratory, Stockholm 17165, Sweden., Savage SA; Clinical Genetics Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, MD 20852, USA., Larsson O; Department of Oncology and Pathology, Karolinska Institutet, Solna 17165, Sweden.; Science for Life Laboratory, Stockholm 17165, Sweden., Ule J; The Francis Crick Institute, London NW1 1AT, UK.; UK Dementia Research Institute, King's College London, London W1T 7NF, UK.; National Institute of Chemistry, 1001 Ljubljana, Slovenia., Baranello L; Department of Cell and Molecular Biology, Karolinska Institutet, Solna 17165, Sweden., Agostini F; Science for Life Laboratory, Stockholm 17165, Sweden.; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna 17165, Sweden., Farnebo M; Department of Cell and Molecular Biology, Karolinska Institutet, Solna 17165, Sweden.; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge 14152, Sweden.
Publikováno v:
Science advances [Sci Adv] 2023 Jul 28; Vol. 9 (30), pp. eadg1805. Date of Electronic Publication: 2023 Jul 28.
Autor:
Bergstrand S; Department of Biosciences and Nutrition, Neo, Karolinska Institutet, Stockholm, Sweden., O'Brien EM; Department of Cell and Molecular biology, Biomedicum, Karolinska Institutet, Stockholm, Sweden., Coucoravas C; Department of Cell and Molecular biology, Biomedicum, Karolinska Institutet, Stockholm, Sweden., Hrossova D; Department of Cell and Molecular biology, Biomedicum, Karolinska Institutet, Stockholm, Sweden., Peirasmaki D; Department of Cell and Molecular biology, Biomedicum, Karolinska Institutet, Stockholm, Sweden., Schmidli S; Department of Cell and Molecular biology, Biomedicum, Karolinska Institutet, Stockholm, Sweden., Dhanjal S; Department of Cell and Molecular biology, Biomedicum, Karolinska Institutet, Stockholm, Sweden., Pederiva C; Department of Cell and Molecular biology, Biomedicum, Karolinska Institutet, Stockholm, Sweden., Siggens L; Department of Biosciences and Nutrition, Neo, Karolinska Institutet, Stockholm, Sweden., Mortusewicz O; Department of Oncology and Pathology, SciLife, Karolinska Institutet, Stockholm, Sweden., O'Rourke JJ; Department of Cell and Molecular biology, Biomedicum, Karolinska Institutet, Stockholm, Sweden., Farnebo M; Department of Biosciences and Nutrition, Neo, Karolinska Institutet, Stockholm, Sweden. marianne.farnebo@ki.se.; Department of Cell and Molecular biology, Biomedicum, Karolinska Institutet, Stockholm, Sweden. marianne.farnebo@ki.se.
Publikováno v:
Nature communications [Nat Commun] 2022 Feb 23; Vol. 13 (1), pp. 1015. Date of Electronic Publication: 2022 Feb 23.
Autor:
Ranhem C; Department of Women's and Children's Health, Karolinska Institutet, 171 77 Stockholm, Sweden.; Centre for Clinical Research Region Västmanland, Uppsala University, Västmanlands Hospital Västerås, 721 89 Västerås, Sweden., Larsson GL; School of Health and Medical Sciences, Örebro University, Campus USÖ, 701 82 Örebro, Sweden.; Department of Laboratory Medicine, Örebro University Hospital, 701 85 Örebro, Sweden., Lindqvist D; Department of Radiation Sciences, Umeå Universitet, 901 87 Umeå, Sweden., Sorbe B; Department of Oncology, Örebro University Hospital, 701 85 Örebro, Sweden., Karlsson MG; School of Medical Sciences, Örebro University, 701 85 Örebro, Sweden., Farnebo M; Department of Bioscience and Nutrition, Karolinska Institutet, 141 83 Stockholm, Sweden.; Department of Cell and Molecular Biology, Karolinska Institutet, 171 77 Stockholm, Sweden., Hellman K; Department of Oncology-Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden., Kovaleska L; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of National Academy of Sciences of Ukraine, 03022 Kiev, Ukraine., Kashuba E; R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of National Academy of Sciences of Ukraine, 03022 Kiev, Ukraine.; Department of Microbiology, Tumour and Cell Biology, Karolinska Institutet, 171 65 Stockholm, Sweden., Andersson S; Department of Women's and Children's Health, Karolinska Institutet, 171 77 Stockholm, Sweden.
Publikováno v:
Oncology letters [Oncol Lett] 2022 Jan; Vol. 23 (1), pp. 30. Date of Electronic Publication: 2021 Nov 23.
Autor:
Bergstrand S; Department of Bioscience and Nutrition, Karolinska Institutet, Stockholm, Sweden., Böhm S; Department of Cell and Molecular Biology (CMB), Karolinska Institutet, Stockholm, Sweden., Malmgren H; Department of Molecular Medicine and Surgery, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden., Norberg A; Department of Medical Biosciences, Medical and Clinical Genetics, Umeå University, Umeå, Sweden., Sundin M; Section of Hematology, Immunology and HSCT, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.; Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden., Nordgren A; Department of Molecular Medicine and Surgery, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden., Farnebo M; Department of Bioscience and Nutrition, Karolinska Institutet, Stockholm, Sweden. marianne.farnebo@ki.se.; Department of Cell and Molecular Biology (CMB), Karolinska Institutet, Stockholm, Sweden. marianne.farnebo@ki.se.
Publikováno v:
Cell death & disease [Cell Death Dis] 2020 Apr 17; Vol. 11 (4), pp. 238. Date of Electronic Publication: 2020 Apr 17.
Autor:
Farnebo M; Department of Bioscience and Nutrition & Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden. marianne.farnebo@ki.se.
Publikováno v:
Nature reviews. Molecular cell biology [Nat Rev Mol Cell Biol] 2020 Feb; Vol. 21 (2), pp. 65.
Neutralization of the Positive Charges on Histone Tails by RNA Promotes an Open Chromatin Structure.
Autor:
Dueva R; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden., Akopyan K; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden., Pederiva C; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden., Trevisan D; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden., Dhanjal S; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden., Lindqvist A; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden., Farnebo M; Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden. Electronic address: marianne.farnebo@ki.se.
Publikováno v:
Cell chemical biology [Cell Chem Biol] 2019 Oct 17; Vol. 26 (10), pp. 1436-1449.e5. Date of Electronic Publication: 2019 Aug 22.